Phibro Animal Health Corporation / Fundamentals
Income statement
- Net revenue
€1.11B - Cost of goods sold
€769.00M - Gross profit
€343.15M - SG&A expenses
€248.37M - R&D expenses
€0.00 - EBITDA
€123.67M - D&A
€39.13M - EBIT
€94.78M - Interest expenses
€26.48M - EBT
€58.34M - Tax expenses
€16.93M - Net income
€41.41M
Cash flow statement
- Net deferred tax
-€4.19M - Non-cash items
-€8.22M - Changes in working capital
€0.00 - Operating cash flow
€68.75M - Capex
€32.86M - Other investing cash flow
€972.97K - Net investing cash flow
-€247.69M - Total cash dividends paid
-€16.69M - Issuance of common stock
€0.00 - Debt repayment
-€0.00 - Other financing cash flow
€194.41M - Net financing cash flow
€177.72M - Foreign exchange effects
-€981.55K - Net change in cash
-€2.21M - Cash at end of period
€58.38M - Free cash flow
€101.60M
Balance sheet
- Cash and cash equivalents
€58.38M - Cash and short-term investments
€66.10M - Total receivables
€195.61M - Inventory
€381.32M - Other current assets
€52.47M - Total current assets
€695.50M - Property, plant & equipment
€304.32M - Goodwill
€51.18M - Intangible assets
€31.29M - Long-term investments
€0.00 - Other non-current assets
€85.36M - Total non-current assets
€472.15M - Total assets
€1.17B - Accounts payable
€118.58M - Short-term debt
€0.00 - Other current liabilities
€14.65M - Total current liabilities
€251.80M - Long-term debt
€528.04M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€142.69M - Total non-current liabilities
€670.74M - Total liabilities
€922.54M - Common stock
€3.43K - Retained earnings
€233.98M - Other equity
-€106.41M - Total equity
€245.12M - Total liabilities and shareholders' equity
€1.17B
Company information
- Market capitalization
€887.15M - Employees
1.9K - Enterprise Value
€1.70B
Company ratios
- Gross margin
-
30.9% Much worse than peer group: 684.9% - EBITDA margin
-
11.1% Much worse than peer group: 1,396,221.0% - EBIT margin
-
8.5% Much worse than peer group: 1,314,912.3% - EBT margin
-
5.2% Much worse than peer group: 1,396,644.9% - Net margin
-
3.7% Much worse than peer group: 1,266,214.3% - ROE
-
16.9% Much better than peer group: -18.9% - ROA
-
3.5% Better than peer group: -12.2% - Asset turnover
-
95.2% Much better than peer group: 48.6% - FCF margin
-
3.2% Much worse than peer group: 982,159.7% - FCF yield
4.0% - Efficiency ratio
88.9% - Net sales per employee
-
€573.28K - Net income per employee
-
€21.35K